Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance.

Raha P, Thomas S, Munster PN.

Epigenomics. 2011 Aug;3(4):451-70. doi: 10.2217/epi.11.72. Review.

PMID:
22126205
2.

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

Clarke R, Liu MC, Bouker KB, Gu Z, Lee RY, Zhu Y, Skaar TC, Gomez B, O'Brien K, Wang Y, Hilakivi-Clarke LA.

Oncogene. 2003 Oct 20;22(47):7316-39. Review.

PMID:
14576841
3.
4.

Overcoming endocrine resistance in breast cancer.

Madaio RA, Spalletta G, Cravello L, Ceci M, Repetto L, Naso G.

Curr Cancer Drug Targets. 2010 Aug;10(5):519-28. Review.

PMID:
20384578
5.
6.

Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.

Han Y, Yang L, Suarez-Saiz F, San-Marina S, Cui J, Minden MD.

Mol Cancer Res. 2008 Aug;6(8):1347-55. doi: 10.1158/1541-7786.MCR-07-2179.

7.

BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.

Brinkman A, van der Flier S, Kok EM, Dorssers LC.

J Natl Cancer Inst. 2000 Jan 19;92(2):112-20.

PMID:
10639512
8.

New approaches to reverse resistance to hormonal therapy in human breast cancer.

Weinberg OK, Marquez-Garban DC, Pietras RJ.

Drug Resist Updat. 2005 Aug;8(4):219-33. Review.

PMID:
16054421
9.

Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities.

Massarweh S, Schiff R.

Clin Cancer Res. 2007 Apr 1;13(7):1950-4. Review.

10.

Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer.

Osborne CK, Shou J, Massarweh S, Schiff R.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):865s-70s. Review.

11.

Therapeutic targeting in the estrogen receptor hormonal pathway.

Katzenellenbogen BS, Frasor J.

Semin Oncol. 2004 Feb;31(1 Suppl 3):28-38. Review.

PMID:
15052541
12.

Molecular and pharmacological aspects of antiestrogen resistance.

Clarke R, Skaar TC, Bouker KB, Davis N, Lee YR, Welch JN, Leonessa F.

J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):71-84. Review.

PMID:
11384865
13.

Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.

Godinho M, Meijer D, Setyono-Han B, Dorssers LC, van Agthoven T.

J Cell Physiol. 2011 Jul;226(7):1741-9. doi: 10.1002/jcp.22503.

PMID:
21506106
14.
15.

Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.

Hoffmann J, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Künzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR.

J Natl Cancer Inst. 2004 Feb 4;96(3):210-8.

PMID:
14759988
16.

[Hormone resistance and its modulation in breast cancer].

Kahán Z, Thurzó L.

Orv Hetil. 2005 Apr 17;146(16):731-7. Review. Hungarian.

PMID:
15889669
17.

Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.

Schiff R, Massarweh SA, Shou J, Bharwani L, Arpino G, Rimawi M, Osborne CK.

Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:10-20. Review.

PMID:
16273359
18.

Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells.

Kilker RL, Hartl MW, Rutherford TM, Planas-Silva MD.

J Steroid Biochem Mol Biol. 2004 Sep;92(1-2):63-71.

PMID:
15544931
19.

Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations.

Gururaj AE, Rayala SK, Vadlamudi RK, Kumar R.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 2):1001s-1007s. Review.

20.

Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors.

Johnston SR, Lu B, Dowsett M, Liang X, Kaufmann M, Scott GK, Osborne CK, Benz CC.

Cancer Res. 1997 Sep 1;57(17):3723-7.

Items per page

Supplemental Content

Support Center